G20 nations must strengthen the global R&D architecture to bolster health preparedness and equity
GHTC statement in advance of the first G20 Health Working Group meeting under the Indonesian presidency.
GHTC statement in advance of the first G20 Health Working Group meeting under the Indonesian presidency.
In advance of the 150th session of the World Health Organization (WHO) Executive Board, GHTC is calling on WHO and member states to strengthen vaccine-related research and innovation to advance next-generation COVID-19 vaccines that address variants and delivery challenges, new vaccines to combat the growing threat of antimicrobial resistance, and new innovations to improve manufacturing and vaccine storage and administration.
In advance of the 150th session of the World Health Organization (WHO) Executive Board, GHTC is urging WHO and member states, as part of the WHO road map for neglected tropical diseases (NTDs), to address key gaps is our arsenal of NTD interventions—including diagnostic, treatments, and pediatric therapies—by increasing investments in NTD R&D and improving WHO guidance and regulatory processes for in-vitro diagnostics.
In advance of the 150th session of the World Health Organization (WHO) Executive Board, GHTC is calling on WHO and member states to increase investments in tuberculosis (TB) R&D, enhance protocol coordination and data sharing platforms, and streamline guidance processes for new tools to accelerate the development of and equitable access to TB products.